Έμβλημα Κυπριακής Δημοκρατίας

News


Notification of a concentration concerning the acquisition of the share capital of Quinag Acquisition (FDI) Limited by KKR & Co. Inc., via Hulk Asia Holdings II Pte. Ltd.
30/05/2024


The Service of the Commission for the Protection of Competition has received a notification of a concentration according to Section 10 (4) of the Control of Concentrations between Enterprises Law of 2014, concerning the acquisition of Quinag Acquisition (FDI) Limited by KKR & Co. Inc., via Hulk Asia Holdings II Pte. Ltd.

KKR & Co. Inc., is a global investment firm offering alternative asset management as well as capital markets and insurance solutions. KKR finances investment funds that invest in private equity, credit and real estate and has strategic partners that manage hedge funds.

Hulk Asia Holdings II Pte. Ltd is a special purpose vehicle established for the purposes of the proposed transaction and is indirectly wholly owned by investment funds, vehicles and/or accounts advised and managed by KKR.

Target of the proposed transaction is Quinag Acquisition (FDI) Limited and its subsidiaries Healthium Medtech Limited and Carenow Lifesciences Private Limited. Healthium Medtech Limited is an unlisted, public medical device company based in India active in the manufacturing, sales and marketing of products used in surgical and post-operative care. Carenow Lifesciences Private Limited is based in India and is active in the research, development, design, testing, manufacturing and sale of non-prescription infection control / personal care and personal hygiene products.







  Twitter Icon  Facebook Icon

Cartel Hotline

Commission Decisions

whistleblowers

e-procurement

GDPR

About Cyprus

Your Europe